In a discovery that challenges over a century of established hematological dogma, researchers at the University of California, San Francisco (UCSF) have demonstrated that the lungs play a far more sophisticated role in the human body than simply facilitating gas exchange. For decades, the scientific community operated under the assumption that the bone marrow was the primary, if not the exclusive, site of blood production in adults. However, a landmark study published on February 27 in the journal Blood reveals that the lungs are a significant site for hematopoiesis—the process of creating new blood cells—and serve as a critical reservoir for hematopoietic stem cells (HSCs).
The implications of this finding are profound, potentially reshaping the medical understanding of organ function, the treatment of blood-related malignancies, and the methodology behind life-saving stem cell transplants. Led by Mark Looney, MD, a professor of medicine and laboratory medicine at UCSF, the research team has identified that the human lung contains a thriving population of stem cells capable of producing red blood cells, immune cells, and platelets. This discovery suggests that the respiratory system is an integral component of the circulatory and regenerative systems, acting as a secondary engine for the 200 billion new red blood cells the body must produce daily to maintain oxygenation across all vital organs.
The Evolutionary Shift: From Mouse Models to Human Confirmation
The journey toward this discovery began several years ago in a laboratory setting. In 2017, Dr. Looney’s team published a provocative study involving mouse models. Utilizing a sophisticated imaging technique known as two-photon intravital imaging, they observed the microcirculation of the mouse lung in real-time. To their surprise, they found that a significant majority of the mouse’s platelets—roughly 50 percent—were being produced within the lung’s vasculature, rather than the bone marrow.
Furthermore, the 2017 study identified a previously unrecognized population of hematopoietic stem cells residing in the extravascular space of the mouse lung. These cells were not merely transient travelers; they were resident progenitors capable of reconstituting the entire blood system in mice that had been depleted of bone marrow stem cells. While the mouse study was groundbreaking, the scientific community remained cautious about whether these findings would translate to human physiology.
To bridge this gap, the UCSF team, supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH), spent the intervening years conducting a rigorous comparative analysis of human tissues. They obtained samples of human lung, bone marrow, and peripheral blood from organ donors and surgical patients to determine if the human lung harbored a similar "reservoir" of blood-forming potential.
Methodology and Comparative Analysis of Tissue Samples
The research team, led by first author Catharina Conrad, MD, PhD, a postdoctoral scholar in Looney’s lab, utilized a meticulous screening process to isolate and identify stem cells within human tissue. By analyzing a volume of lung tissue roughly the size of a golf ball, the scientists identified cells that expressed the same surface markers—the molecular "ID tags"—as the well-known hematopoietic stem cells found in bone marrow.
The quantitative data revealed a surprising parity. The researchers found that HSCs were present in the human lung at concentrations remarkably similar to those found in the bone marrow. To verify that these cells were functional and not just dormant remnants, the team conducted "gold-standard" stem cell experiments. They placed the lung-derived HSCs in petri dishes under conditions designed to stimulate growth and maturation.
The results confirmed that the lung HSCs were highly productive. When compared side-by-side with bone marrow HSCs, the lung-derived cells thrived and successfully matured into various blood components. However, a notable functional specialization emerged: while bone marrow HSCs tended to produce a higher proportion of immune cells (leukocytes), the lung HSCs were significantly more efficient at producing red blood cells and megakaryocytes—the large cells responsible for producing the platelets that allow blood to clot.
The Perivascular Niche: Evidence of Permanent Residency
A critical question for the researchers was whether these stem cells were truly residents of the lung or simply "escapees" from the bone marrow that had become trapped in the lung’s dense capillary network. To answer this, Dr. Conrad and her colleagues performed high-resolution imaging of human lung tissue.
They discovered the HSCs nestled in specific anatomical locations between blood vessels, an arrangement known as a perivascular niche. This structural organization closely mirrors the environment of the bone marrow, providing the necessary signals and support for stem cell maintenance and differentiation. The presence of these cells in dedicated niches suggests that they are permanent residents of the lung, integrated into the organ’s architecture to serve as a local source of blood production.
"They really seem to live there and aren’t just passing through," Dr. Conrad noted. This residency status is vital because it implies that the lung has its own internal mechanism for responding to physiological stress, such as blood loss or low oxygen levels, without relying solely on signals sent to the distant bone marrow.
Redefining the "Bone Marrow" Transplant
Perhaps the most immediate clinical revelation of the study involves the current practice of hematopoietic stem cell transplantation (HSCT), commonly referred to as a bone marrow transplant. In modern medicine, these transplants often do not involve the direct harvesting of marrow from bone. Instead, donors are given medications to "mobilize" stem cells into their bloodstream, where they are then collected via a blood draw.
The UCSF team analyzed the molecular signatures of stem cells collected during these routine donor procedures. Remarkably, they found that nearly 20 percent of the stem cells currently used in "bone marrow transplants" actually carry the unique molecular signature of lung-derived HSCs. This suggests that for decades, clinicians have been unknowingly transplanting lung stem cells into patients with leukemia, lymphoma, and other blood disorders.
This data point provides a new perspective on why transplants are successful. The presence of lung HSCs, which are specialized for red blood cell and platelet production, likely complements the bone marrow HSCs, which focus on rebuilding the recipient’s immune system. This synergy between different pools of stem cells may be a key factor in the rapid recovery of blood counts following a transplant.
Broader Implications and Future Therapeutic Potential
The discovery of a secondary blood-forming reservoir in the lungs opens a new frontier in regenerative medicine and hematology. Dr. Looney and his team hypothesize that the lung serves as an "emergency reservoir" for the body. Because the lungs are the primary site of oxygenation and are central to the circulatory system, having a local source of red blood cell and platelet production allows the body to respond rapidly to acute needs.
For patients suffering from chronic lung diseases, such as pulmonary fibrosis or chronic obstructive pulmonary disease (COPD), this research raises critical questions. If the lung is damaged, is its ability to contribute to blood production also compromised? Conversely, could certain types of anemia or platelet disorders be treated by targeting the lung’s stem cell population?
Furthermore, the identification of the lung as a potent source of HSCs could lead to more efficient methods of stem cell harvesting. If researchers can determine how to specifically activate the lung’s reservoir, it might be possible to increase the yield of high-quality stem cells for transplants, potentially improving outcomes for patients with aggressive cancers like leukemia.
Conclusion: A New Chapter in Respiratory and Hematologic Science
The findings from UCSF represent a significant shift in how the medical community views the division of labor among human organs. While the bone marrow remains a central pillar of hematopoiesis, the lung has now been elevated to the status of a co-producer and a vital backup system.
"The lungs are critical to blood circulation, so it’s tantalizing to see the lung HSCs as an emergency reservoir for red blood cell and platelet production," Dr. Looney concluded. "Now that we know they exist, it opens up a lot of new opportunities for a therapy, hematopoietic stem cell transplantation, that is very commonly used for patients with the need."
As research continues, the focus will likely turn to the signaling pathways that govern these lung HSCs and how they communicate with the bone marrow. For now, the study stands as a reminder that even in an era of advanced medical imaging and genetic sequencing, the human body still holds fundamental secrets waiting to be uncovered. The breath of life, it seems, is even more deeply connected to the flow of blood than previously imagined.
Leave a Reply